ANRO (Alto Neuroscience) Total Long-Term Assets : $8.21 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Alto Neuroscience Total Long-Term Assets?

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Alto Neuroscience's Total Long-Term Assets for the quarter that ended in Dec. 2024 was $8.21 Mil.

Alto Neuroscience Total Long-Term Assets Historical Data

The historical data trend for Alto Neuroscience's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alto Neuroscience Total Long-Term Assets Chart

Alto Neuroscience Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Total Long-Term Assets

1.11

1.63

1.24

8.21

Alto Neuroscience Quarterly Data
	Dec21	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Long-Term Assets	Get a 7-Day Free Trial					1.24	1.61	1.95	8.08	8.21

Alto Neuroscience Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Alto Neuroscience Total Long-Term Assets Related Terms

Thank you for viewing the detailed overview of Alto Neuroscience's Total Long-Term Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Alto Neuroscience Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Total Long-Term Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

650 Castro Street, Suite 450, Mountain View, CA, USA, 94041

Website

https://www.altoneuroscience.com

Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.